Our Company

MEDAX IS SYNONYMOUS WITH BIOPSY

Since its creation in 2000, rooted in a biomedical district of Northern Italy, MEDAX has grown to become a leading manufacturer of Biopsy Needles and Instruments, marketing their high quality products throughout Europe, North America, Asia, Africa and Latin America.

The company’s core principles include a strong customer orientation, fully integrated manufacturing, and high quality products manufactured to exacting standards, and ongoing research and development.

All company activities, ultimately, are aimed at improving healthcare outcomes and the patient experience.

MEDAX launched their expansive product portfolio into the India, covering all aspects of percutaneous, image guided soft tissue biopsy, as well as bone marrow biopsy.

MEDAX’s commitment to the Indian  Market includes a state of the art warehouse and distribution center located Mumbai.

In addition to our centralized distribution center, all MEDAX products are sold and serviced by a network of local/regional distributors who also stock the full range of MEDAX products.  To place an order for any MEDAX biopsy product, please consult the list of distributors who are part of the website.

Medax Medical Devices India Private Limited
Registered Office
: 602, Charkop, Mitashu Chs Ltd, R D P 6, Sector 6, Near TJSB Bank, Kandivali (W), Mumbai, 400067, Mumbai City, Maharashtra, India.
Warehouse: Shop No.1, Mahasagar Chs, Plot No. 112, Sector No.4, Opp Haryana Bhavan, Charkop,Kandivali West , Mumbai 400067, Maharashtra, India. - This email address is being protected from spambots. You need JavaScript enabled to view it. 

MEDAX S.R.L. Unipersonale
Via Sandro Pertini, 4 - 41039 - San Possidonio (MO) - Italy
Company direct No. : +39 0535 1812757  This email address is being protected from spambots. You need JavaScript enabled to view it.

Vat N. /Fiscal Code N. Iscriz. Reg. Impr.  MN 02669860369 - N. REA: MO 403036 - Capitale Sociale Euro 100.011,00 i.v.

In accordance with the requirements of the medical device 93/42/EEC directive and its relevant updates. All products undergo intensive clinical testing and are fully EC and FDA approved.